Free-cash-flow proxy increased 51.0%
Free-cash-flow proxy changed +51.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +51.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +51.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -31.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +151.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +33.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +42.4% from the comparable as-filed period.
Total assets changed -13.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -38.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -1626 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +10772 basis points from the comparable as-filed period.
Current assets changed -17.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +70.8% from the comparable as-filed period.
Cash & equivalents changed -17.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed -42.3% from the comparable as-filed period.
SBC / revenue changed +1440 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed -72.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory / revenue changed -7175 basis points from the comparable as-filed period.
R&D / revenue changed -7319 basis points from the comparable as-filed period.
Free-cash-flow margin changed +6983 basis points from the comparable as-filed period.
Operating cash-flow margin changed +6983 basis points from the comparable as-filed period.
Shares outstanding changed +13.5% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
Revenue changed +3.0% from the comparable as-filed period.
Capex / revenue changed +0 basis points from the comparable as-filed period.
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.